compound 13c [PMID: 20684591]   Click here for help

GtoPdb Ligand ID: 9681

Compound class: Synthetic organic
Comment: Compound 13c [PMID: 20684591] is a potent, orally active and competitive inhibitor of all three isoforms of protein kinase D [2]. It is one of the chemical structures claimed in Novartis' patent WO2008122615 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 65.97
Molecular weight 388.24
XLogP 4.22
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CCC(CC1)Nc1nccc(c1)c1cc2cnccc2c(n1)N1CCNCC1
Isomeric SMILES C1CCC(CC1)Nc1nccc(c1)c1cc2cnccc2c(n1)N1CCNCC1
InChI InChI=1S/C23H28N6/c1-2-4-19(5-3-1)27-22-15-17(6-9-26-22)21-14-18-16-25-8-7-20(18)23(28-21)29-12-10-24-11-13-29/h6-9,14-16,19,24H,1-5,10-13H2,(H,26,27)
InChI Key DIZACSOTRSXCHC-UHFFFAOYSA-N
Bioactivity Comments
Compound 13c inhibits all three isoforms of protein kinase D with similar potency [2]. In an HDAC nuclear export assay (a cellular readout of PKD activity), compound 13c inhibited PGF2α-induced nuclear export of GFP-HDAC5 in cardiac myocytes with an IC50 of 32nM. In vivo, 13c reduced cardiac hypertrophy in two rat models. Off target kinase inhibition (inhibited by >50% at 1 μM 13c) was detected for GSK3β, CaMKIIβ, CaMKIIγ, CaMKIIδ and MARK1.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
protein kinase D1 Hs Inhibitor Inhibition 9.2 pIC50 - 2
pIC50 9.2 (IC50 6x10-10 M) [2]
Description: Measuring inhibition of synthetic substrate phosphorylation in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.